Viewpoint

Redefining Progression in a Rapidly Evolving Therapeutic Landscape

JAMA Oncology 10.1001/jamaoncol.2026.2830

August 13, 2026 at 11:00 AM EDT

Read the full article

This Viewpoint the regulatory problem of how to design clean trials that regulators seek as the field of oncology becomes more therapeutically sophisticated.

Corresponding Author: Neil Vasan, MD, PhD, Department of Medicine, NYU Grossman School of Medicine, Perlmutter Cancer Center, NYU Langone Health, 522 First Ave, Smilow Building, Room 1310, New York, NY 10016 (neil.vasan@nyulangone.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2026.2830?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081326

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks